Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) were up 1% during mid-day trading on Thursday . The company traded as high as $5.22 and last traded at $5.21. Approximately 8,164 shares were traded during trading, a decline of 59% from the average daily volume of 19,819 shares. The stock had previously closed at $5.1565.
Ono Pharmaceutical Price Performance
The firm’s 50 day simple moving average is $4.70 and its 200-day simple moving average is $4.18.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- He just nailed another gold prediction …
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
